NCT00238238 Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab Status COMPLETED Phase PHASE2
NCT00237627 Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00234169 A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone Status COMPLETED Phase PHASE1/PHASE2
NCT00234026 Gemcitabine in Treating Patients With Newly Diagnosed, Relapsed, or Chemotherapy-Resistant Mantle Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00233987 S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00227695 Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE3
NCT00225212 Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00217503 Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma Status COMPLETED Phase PHASE2
NCT00217425 Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms Status COMPLETED Phase PHASE2
NCT00215605 Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT00214370 Propofol Versus Propofol-Fentanyl as Sedation For Lumbar Puncture in Children With Acute Leukemia/Lymphoma Status COMPLETED Phase NA
NCT00210249 Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment Status COMPLETED Phase N/A
NCT00208975 Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and Rituximab Status TERMINATED Phase PHASE2
NCT00207298 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology Status COMPLETED Phase N/A
NCT00195897 Early Assessment of Anthracycline-induced Cardiotoxicity (CARDIOTOX) Status TERMINATED Phase N/A
NCT00195533 Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients Status COMPLETED Phase N/A
NCT00186940 Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients Status COMPLETED Phase N/A